{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T21:56:10Z","timestamp":1776462970394,"version":"3.51.2"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T00:00:00Z","timestamp":1621814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.biopha.2021.111777","type":"journal-article","created":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T15:29:43Z","timestamp":1625671783000},"page":"111777","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["A study of altered calcium sensing system caused primary membranous nephropathy to end-stage renal failure"],"prefix":"10.1016","volume":"141","author":[{"given":"Lan","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Juan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiao-Rong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gui-Cai","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2021.111777_bib1","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1681\/ASN.2016040449","article-title":"Rituximab for severe membranous nephropathy: a 6-month trial with extended follow-up","volume":"28","author":"Dahan","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111777_bib2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1681\/ASN.2016070776","article-title":"A proposal for a serology-based approach to membranous nephropathy","volume":"28","author":"De Vriese","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111777_bib3","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s10157-017-1437-2","article-title":"Rituximab in primary membranous nephropathy: beyond a B-cell-centered paradigm?","volume":"22","author":"Esposito","year":"2018","journal-title":"Clin. Exp. Nephrol."},{"issue":"4","key":"10.1016\/j.biopha.2021.111777_bib4","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.kint.2020.10.014","article-title":"The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy","volume":"99","author":"Fern\u00e1ndez-Ju\u00e1rez","year":"2021","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.biopha.2021.111777_bib5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa1814427","article-title":"Rituximab or cyclosporine in the treatment of membranous nephropathy","volume":"381","author":"Fervenza","year":"2019","journal-title":"N. Engl. J. Med"},{"issue":"1","key":"10.1016\/j.biopha.2021.111777_bib6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11010-014-2064-9","article-title":"Protective effect of pioglitazone, a PPAR\u03b3 agonist against acetaminophen-induced hepatotoxicity in rats","volume":"393","author":"Gupta","year":"2014","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.biopha.2021.111777_bib7","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/j.ajkd.2016.01.030","article-title":"Membranous nephropathy: a journey from bench to bedside","volume":"68","author":"Francis","year":"2016","journal-title":"Am. J. Kidney Dis."},{"issue":"1","key":"10.1016\/j.biopha.2021.111777_bib8","first-page":"17","article-title":"Tumor suppressor role of miR-503","volume":"60","author":"Gupta","year":"2017","journal-title":"Panminerva Med."},{"key":"10.1016\/j.biopha.2021.111777_bib9","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s10787-020-00698-3","article-title":"Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases:an update","volume":"28","author":"Mehta","year":"2020","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.biopha.2021.111777_bib10","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.923454","article-title":"Choroidal neovascularization in primary membranous nephropathy","volume":"21","author":"Gambato","year":"2020","journal-title":"Am. J. Case Rep."},{"issue":"6","key":"10.1016\/j.biopha.2021.111777_bib11","first-page":"693","article-title":"Clinical significance of M-type phospholipase A2 receptor and thrombospondin Type 1 domain-containing 7A in primary membranous nephropathy","volume":"45","author":"Gong","year":"2020","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"1","key":"10.1016\/j.biopha.2021.111777_bib12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1080\/0886022X.2020.1713806","article-title":"Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy","volume":"42","author":"Guo","year":"2020","journal-title":"Ren. Fail."},{"issue":"1","key":"10.1016\/j.biopha.2021.111777_bib13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.23736\/S0031-0808.18.03398-0","article-title":"Current updates on biological and pharmacological activities of doxycycline","volume":"60","author":"Devi","year":"2018","journal-title":"Panminerva Med."},{"issue":"1","key":"10.1016\/j.biopha.2021.111777_bib14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1615\/IntJMedMushrooms.2018025303","article-title":"Aphrodisiac activity of an aqueous extract of wood ear mushroom, Auricularia polytricha (Heterobasidiomycetes), in male rats","volume":"20","author":"Gupta","year":"2018","journal-title":"Int. J. Med. Mushrooms"},{"issue":"5","key":"10.1016\/j.biopha.2021.111777_bib15","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.semnephrol.2017.05.017","article-title":"Translational aspects of primary membranous nephropathy","volume":"37","author":"Hoxha","year":"2017","journal-title":"Semin. Nephrol."},{"issue":"4","key":"10.1016\/j.biopha.2021.111777_bib16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s13730-019-00399-z","article-title":"Membranous nephropathy caused by rheumatoid arthritis","volume":"8","author":"Iida","year":"2019","journal-title":"CEN Case Rep."},{"issue":"7","key":"10.1016\/j.biopha.2021.111777_bib17","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/1756-185X.13602","article-title":"Rosmarinic acid attenuates inflammation in experimentally induced arthritis in Wistar rats, using Freund\u2019s complete adjuvant","volume":"22","author":"Gautam","year":"2019","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.biopha.2021.111777_bib18","series-title":"Pharmacology of Endocannabinoids and Their Receptors, Frontiers in Pharmacology of Neurotransmitters","first-page":"415","author":"Gupta","year":"2020"},{"issue":"5","key":"10.1016\/j.biopha.2021.111777_bib19","first-page":"1993","article-title":"Advances of the experimental models of idiopathic membranous nephropathy (Review)","volume":"21","author":"Jiang","year":"2020","journal-title":"Mol. Med. Rep."},{"issue":"9","key":"10.1016\/j.biopha.2021.111777_bib20","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2217\/bmm-2017-0081","article-title":"A comprehensive narrative review of diagnostic biomarkers in human primary membranous nephropathy","volume":"11","author":"Kalantari","year":"2017","journal-title":"Biomark. Med."},{"key":"10.1016\/j.biopha.2021.111777_bib21","first-page":"232","article-title":"Activation of TWEAK\/Fn14 signaling suppresses TRAFs\/NF-\u03baB pathway in the pathogenesis of cancer","volume":"20","author":"Gupta","year":"2021","journal-title":"EXCLI J."},{"key":"10.1016\/j.biopha.2021.111777_bib22","series-title":"Role of Oxidative Stress in Pathophysiology of Diseases","first-page":"107","article-title":"Oxidative stress and immunological complexities in multidrug-resistant tuberculosis","author":"Wadhwa","year":"2020"},{"issue":"1","key":"10.1016\/j.biopha.2021.111777_bib23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4103\/ijn.IJN_8_18","article-title":"Early recurrent primary membranous nephropathy detected in an allograft biopsy","volume":"29","author":"Kaur","year":"2019","journal-title":"Indian J. Nephrol."},{"issue":"6","key":"10.1016\/j.biopha.2021.111777_bib24","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1615\/CritRevEukaryotGeneExpr.2019027836","article-title":"Current update on preclinical and clinical studies of resveratrol, a naturally occurring phenolic compound","volume":"29","author":"Samuel","year":"2019","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"10.1016\/j.biopha.2021.111777_bib25","doi-asserted-by":"crossref","first-page":"170","DOI":"10.23736\/S0031-0808.18.03467-5","article-title":"3D-printing: an emerging and a revolutionary technology in pharmaceuticals","volume":"60","author":"Singhvi","year":"2018","journal-title":"Panminerva Med."},{"issue":"1119","key":"10.1016\/j.biopha.2021.111777_bib26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/postgradmedj-2018-135729","article-title":"Primary membranous nephropathy: comprehensive review and historical perspective","volume":"95","author":"Keri","year":"2019","journal-title":"Postgrad. Med. J."},{"issue":"2","key":"10.1016\/j.biopha.2021.111777_bib27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ddr.21492","article-title":"Microsponge: an emerging drug delivery strategy","volume":"80","author":"Singhvi","year":"2019","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.biopha.2021.111777_bib28","first-page":"742","article-title":"Recent update on biological activities and pharmacological actions of liraglutide","volume":"16","author":"Tiwari","year":"2017","journal-title":"EXCLI J."},{"issue":"2","key":"10.1016\/j.biopha.2021.111777_bib29","doi-asserted-by":"crossref","first-page":"531","DOI":"10.4103\/1319-2442.256863","article-title":"Primary membranous nephropathy with concomitant IgA nephropathy","volume":"30","author":"Khorsan","year":"2019","journal-title":"Saudi J. Kidney Dis. Transpl."},{"key":"10.1016\/j.biopha.2021.111777_bib30","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1936372","article-title":"Recent progress in deciphering the etiopathogenesis of primary membranous nephropathy","volume":"2017","author":"Kronbichler","year":"2017","journal-title":"Biomed. Res. Int."},{"issue":"9","key":"10.1016\/j.biopha.2021.111777_bib31","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/nep.12835","article-title":"Primary membranous nephropathy in adolescence: a prospective study","volume":"22","author":"Kumar","year":"2017","journal-title":"Nephrology"},{"key":"10.1016\/j.biopha.2021.111777_bib32","first-page":"635","article-title":"Current biological and pharmacological updates on wogonin","volume":"19","author":"Rawat","year":"2020","journal-title":"EXCLI J."},{"issue":"10","key":"10.1016\/j.biopha.2021.111777_bib33","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1097\/TP.0000000000002758","article-title":"Membranous nephropathy posttransplantation: an update of the pathophysiology and management","volume":"103","author":"Leon","year":"2019","journal-title":"Transplantation"},{"issue":"30","key":"10.1016\/j.biopha.2021.111777_bib34","article-title":"[Primary membranous nephropathy presenting as relapsing ascites]","volume":"179","author":"Lindhard","year":"2017","journal-title":"Ugeskr. Laeger"},{"key":"10.1016\/j.biopha.2021.111777_bib35","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.lfs.2019.05.010","article-title":"Gene polymorphism and risk of idiopathic membranous nephropathy","volume":"229","author":"Liu","year":"2019","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.biopha.2021.111777_bib36","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jep.2012.03.013","article-title":"Sedative, antiepileptic and antipsychotic effects of Viscum album L.(Loranthaceae) in mice and rats","volume":"141","author":"Gupta","year":"2012","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111777_bib37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1615\/JEnvironPatholToxicolOncol.2019029075","article-title":"Role of herbal medicine in the management of urolithiasis\u2014a review for future perspectives","volume":"38","author":"Patle","year":"2019","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111777_bib38","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4103\/ijn.IJN_7_18","article-title":"Primary Membranous glomerulonephritis-associated with schistosomal nephropathy","volume":"29","author":"Mohammad Ibrahim","year":"2019","journal-title":"Indian J. Nephrol."},{"key":"10.1016\/j.biopha.2021.111777_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.611317","article-title":"Secondary membranous nephropathy. A narrative review","volume":"7","author":"Moroni","year":"2020","journal-title":"Front. Med."},{"issue":"5","key":"10.1016\/j.biopha.2021.111777_bib40","first-page":"335","article-title":"Biomarkers in primary membranous nephropathy, a guide to precision medicine","volume":"14","author":"Nafar","year":"2020","journal-title":"Iran. J. Kidney Dis."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222100559X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222100559X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T21:12:52Z","timestamp":1776460372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222100559X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":40,"alternative-id":["S075333222100559X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111777","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A study of altered calcium sensing system caused primary membranous nephropathy to end-stage renal failure","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111777","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111777"}}